Fair Value Measurements (Tables)

12 Months Ended

Jun. 30, 2017

Accelerated Share Repurchases [Line Items]

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]

The recurring Level 3 fair value measurements of our forward share repurchase contract asset include the following significant unobservable inputs:

Unobservable Input	Health Advances	ExecuPharm	TMAC
Risk free rate	1.3%	1.2%	1.5%
Revenue volatility	24%	25%	25%
Projected period of payment	Approximately 2 years	12 months	2.5 years

The recurring Level 3 fair value measurements of our forward share repurchase contract asset include the following significant unobservable inputs:

	Forward Share
Unobservable Input	Repurchase Contract
Risk free rate	0.5%
Share price volatility	37.5%
Contract term	0.2 years

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

(dollars in millions)	Fair Value
Balance at June 30, 2015	$	7.3
Additions of contingent consideration from Health Advances acquisition	4.5
Change in fair value of contingent consideration	8.7
Payment of contingent consideration	(14.1		)
Effect of changes in exchange rates used for translation	(1.2		)
Balance at June 30, 2016	5.2
Additions of contingent consideration	11.5
Change in fair value of contingent consideration	1.3
Balance at June 30, 2017	$	18.0

The following table provides a summary of the change in our valuation of the fair value of the forward accelerated share repurchase contract asset, which was determined by Level 3 inputs:

(in millions)
Balance at June 30, 2016	$	—
Additions of forward share repurchase contract	40.0
Change in fair value of forward share repurchase contract	(20.7		)
Reclass of forward accelerated share repurchase contract to equity	(19.3		)
Balance at June 30, 2017	$	—

Fair Value Hierarchy By Level

(dollars in millions)	Level 1		Level 2		Level 3			Total
Contingent Consideration	$	—	$	—	$	(18.0	)	$	(18.0	)
Interest Rate Derivative Instruments	—		0.7		—			0.7
Foreign Currency Exchange Contracts	—		5.7		—			5.7
Total	$	—	$	6.4	$	(18.0	)	$	(11.6	)

The following table sets forth by level, within the fair value hierarchy, our assets (liabilities) carried at fair value as of June 30, 2016:

(dollars in millions)	Level 1		Level 2			Level 3			Total
Contingent Consideration	$	—	$	—		$	(5.2	)	$	(5.2	)
Interest Rate Derivative Instruments	—		(1.3		)	—			(1.3		)
Foreign Currency Exchange Contracts	—		(5.3		)	—			(5.3		)
Total	$	—	$	(6.6	)	$	(5.2	)	$	(11.8	)